Craig Tilston
Head of Clinical Operations @Redx Pharma
Signup · Get unlimited contacts
WORK HISTORY
Head of Clinical Operations @Redx Pharma
Alderley, GB
Reporting directly to the CMO and serving on the Senior Management Team, accountable for all aspects of clinical development and operations across the company’s pipeline. Lead global clinical trial execution from preclinical through first-in-human and Phase 2, ensuring strategy, timelines, cost, and quality align with scientific and commercial goals.Key contributions:• Built and led the Clinical Operations group, providing strategic oversight of project managers, CROs, and vendors across international studies.• Directed outsourced IND and CTA submissions, engaging directly with MHRA, FDA, and EMA to ensure compliance, quality, and inspection readiness.• Oversaw outsourced preclinical toxicology, regulatory, and pharmacovigilance providers, holding accountability for performance, delivery, and integration into development strategy.• Delivered operational strategy for oncology and fibrosis programs, advancing assets from preclinical into first-in-human and beyond.• Partnered with the CMO and scientific leadership to design and operationalise innovative development plans; provided board-level and investor-facing updates on progress, risks, and opportunities.• Supported business development and fundraising by presenting clinical strategy and data packages in due diligence and investor discussions.• Represented the company at international conferences, engaging KOLs, investigators, and partners, and gathering competitive intelligence.
EDUCATION
University of Exeter
BSc (hons), Chemistry and Law
ABOUT CRAIG TILSTON
Biotech leader with 25+ years’ experience in global clinical development and operations, driving programs from preclinical through first-in-human and Phase 2. Currently Head of Clinical Operations, reporting directly to the CMO and serving on the Senior Management Team, with accountability for global study execution, CRO/vendor oversight, and cross-functional leadership.Proven expertise in IND and CTA submissions, MHRA, EMA, and FDA engagement, with a track record of advancing assets in oncology and fibrosis. Skilled in building and scaling Clinical Operations groups, ensuring regulatory compliance, inspection readiness, and operational excellence across international trials.Recognised for aligning clinical execution with board and investor priorities, delivering data packages that supported financings, partnerships, and strategic value creation. Experienced in presenting clinical strategy to investors, regulators and KOLs, and in establishing operational infrastructure to enable pivotal studies in fast-growing biotech environments.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.